Thorax

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Published Online First: 21 October 2005. doi:10.1136/thx.2005.043547
Thorax 2006;61:57-60
Copyright © 2006 BMJ Publishing Group Ltd & British Thoracic Society

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
thx.2005.043547v1
61/1/57    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Win, T
Right arrow Articles by Laroche, C M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Win, T
Right arrow Articles by Laroche, C M

LUNG CANCER

Comparison of shuttle walk with measured peak oxygen consumption in patients with operable lung cancer

T Win1, A Jackson2, A M Groves3, L D Sharples4, S C Charman4, C M Laroche1

1 Thoracic Oncology Unit, Papworth Hospital, Papworth, Cambridge, UK
2 Respiratory Laboratory, Papworth Hospital, Papworth, Cambridge, UK
3 Radiology and Nuclear Medicine Department, Addenbrooke’s Hospital, Cambridge, UK
4 MRC Biostatistics Unit, Robinson Way, Cambridge, UK

Correspondence to:
Correspondence to:
Dr T Win
Lister Hospital, Stevenage, Hertfordshire SG1 4AB, UK; drthidawin{at}hotmail.com

Background: The relationship between the shuttle walk test and peak oxygen consumption in patients with lung cancer has not previously been reported. A study was undertaken to examine this relationship in patients referred for lung cancer surgery to test the hypothesis that the shuttle walk test would be useful in this clinical setting.

Methods: 125 consecutive patients with potentially operable lung cancer were prospectively recruited. Each performed same day shuttle walking and treadmill walking tests.

Results: Shuttle walk distances ranged from 104 m to 1020 m and peak oxygen consumption ranged from 9 to 35 ml/kg/min. The shuttle walk distance significantly correlated with peak oxygen consumption (r = 0.67, p<0.001). All 55 patients who achieved more than 400 m on the shuttle test had a peak oxygen consumption of at least 15 ml/kg/min. Seventy of 125 patients failed to achieve 400 m on the shuttle walk test; in 22 of these the peak oxygen consumption was less than 15 ml/kg/min. Nine of 17 patients who achieved less than 250 m had a peak oxygen consumption of more than 15 ml/kg/min.

Conclusion: The shuttle walk is a useful exercise test to assess potentially operable lung cancer patients with borderline lung function. However, it tends to underestimate exercise capacity at the lower range compared with peak oxygen consumption. Our data suggest that patients achieving 400 m on the shuttle walk test do not require formal measurement of oxygen consumption. In patients failing to achieve this distance we recommend assessment of peak oxygen consumption, particularly in those unable to walk 250 m, because a considerable proportion would still qualify for surgery as they had an acceptable peak oxygen consumption.


Abbreviations: FEV1, forced expiratory volume in 1 second; KCO, carbon monoxide transfer coefficient; TLCO, carbon monoxide transfer factor, V·O2peak, peak oxygen consumption

Keywords: lung function; lung cancer; shuttle walk test; oxygen consumption; surgery







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2006 BMJ Publishing Group Ltd & British Thoracic Society